Tranche 1 – 12 months following FDA approval, provided that the FDA
approved label for SB includes efficacy and safety data that supports
promotion in the US market (9,333,334 Rights);
This is a bit ridiculous, how is he as CEO from today, really earning 9.33m shares for the approval of SB?
It should be all an internal FDA matter from this point so he's literally making $1.77m+ for doing nothing.
Ann: Appointment of Dr Howie McKibbon as CEO, page-46
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 37.0¢ | $34.71K | 93.82K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 151591 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 9140 | 3 |
View Market Depth
| Last trade - 10.00am 09/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |